Journal article icon

Journal article

Translational molecular imaging in exocrine pancreatic cancer

Abstract:
Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancer cases. Late diagnosis and failure of chemo- and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we will make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's Version

Actions


Access Document


Files:
Publisher copy:
10.1007/s00259-018-4146-5

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Oncology
Role:
Author
Expand authors...
Publisher:
Springer Publisher's website
Journal:
European Journal of Nuclear Medicine and Molecular Imaging Journal website
Volume:
45
Issue:
13
Pages:
2442–2455
Publication date:
2018-09-17
Acceptance date:
2018-08-18
DOI:
EISSN:
1619-7089
ISSN:
1619-7070
Pubs id:
pubs:912175
URN:
uri:c9aaba15-d8e2-4246-a5bf-6b1c20df1949
UUID:
uuid:c9aaba15-d8e2-4246-a5bf-6b1c20df1949
Local pid:
pubs:912175

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP